Is the price and quality of the Vietnamese version of Pemetinib reliable?
Pemigatinib (Pemigatinib) is a targeted therapy drug mainly used to treat cholangiocarcinoma and other solid tumors related to FGFR gene mutations. In the domestic market, pemetinib is sold in the form of pemetinib tablets. The main specifications are 4.5mg×14 tablets and 9mg Although the drug is already on the market, it is not yet covered by medical insurance, so patients need to pay for it out of pocket, which is relatively expensive.
Regarding the Vietnamese version of pemetinib, there is currently no official or authoritative channel confirming that the Vietnamese version of pemetinib is on the market. There is also no public and reliable price information of the Vietnamese version of pemetinib on the market, so it is impossible to determine whether the quality and price of the Vietnamese version of the drug are competitive or safe. Patients should be cautious when looking for overseas versions and avoid purchasing products from unknown or unverified sources.
In overseas markets, consumers can usually choose to purchase generic versions of pemetinib, which have similar ingredients to the original drug and are relatively affordable. For example, pemetinib produced by Lucius Pharmaceuticals in Laos is 4.5 mg × 14 tablets, priced at more than 700 yuan per box, which is far lower than the price of domestic original drugs. The quality supervision is relatively strict and has a certain degree of reliability. However, you still need to choose formal channels when purchasing to ensure the authenticity and safety of the drugs.
In general, there is currently no official or authoritative information on the Vietnamese version of pemetinib. If patients need to purchase pemetinib overseas, they can consider generic drugs from Laos or other countries, but they must purchase it through regular medical institutions or pharmacies to avoid risks. Domestic patients should consult a professional doctor when using it and choose the appropriate medication route based on their own condition and financial situation.
Reference materials:https://www.drugs.com
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)